| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Marker Therapeutics, Inc. | VP, Research and Development | Employee Stock Option (right to buy) | 33,159 | 27 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | 27 Feb 2023 | 1 | $0 | 4 | VP, Research and Development | 01 Mar 2023, 15:52 |
| MRKR | Marker Therapeutics, Inc. | 17 Feb 2022 | 1 | $0 | 4 | VP, Research and Development | 22 Feb 2022, 16:04 |